http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2703705-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_344090d436d27e041b7b9486cfdf560f |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-107 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145 |
filingDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7043d42a8fbf6d7f700b1d3faac3ec4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8f92d47f5b7f34ef6d208c5ee8e7fad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3323fa4cf4046e3690a2530b2cced717 |
publicationDate | 2019-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2703705-C1 |
titleOfInvention | Method of assessing the quality of reconvalescence in infectious mononucleosis in children |
abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to children's infectious diseases, and can be used for monitoring of reconvalescence in infectious mononucleosis (IM) in children. Clinical parameters are determined: frequency of acute respiratory diseases per year, liver size increase. Hematological criteria are determined: relative content of atypical mononuclears, monocytes and lymphocytes. Serological criteria are determined: presence of diagnostic titre of IgM to capsid and IgG to nuclear antigen of Epstein-Barr virus. That is followed by assessing the dynamics of infectious mononucleosis by the following parameters: complaints, manifestations of allergy, size of lymph nodes, liver, spleen sizes, total blood analysis, biochemical blood analysis, general urine analysis. Dynamics of the infectious mononucleosis is evaluated by these parameters 1 month after the doctor's visit, 6 months and thereafter every 6 months to 5 years. Infectious mononucleosis clinical course is evaluated by the following parameters: ARVI frequency per year, microbiological disorders, immunologist conclusion. Infectious mononucleosis is evaluated by parameters 1 year after the doctor's visit, and every next year up to 5 years. Dynamics of infectious mononucleosis is assessed by parameters: PCR, ELISA, IgG early, IgG late to Epstein-Barr virus, cytomegalovirus, herpes simplex virus. Infectious mononucleosis dynamics is assessed by these parameters 6 months after the doctor's visit, 1 year and every next year up to 5 years. During normalization of all laboratory and clinical values within one year, removal from dispensary follow-up is performed.EFFECT: method provides determining infectious process dynamics, differential diagnosis of chronic form and complications of myocardial infarction.1 cl, 4 tbl, 2 ex |
priorityDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 138.